Report Ocean has released a market research report on the Alport Syndrome Treatment industry, covering 150+ countries and analyzing over 1,00000 published and forthcoming reports per year. The report, ...

EMA’s human medicines committee recommends approval of GSK’s single-vial, fully liquid presentation of Menveo meningococcal vaccine: London, UK Wednesday, September 25, 2024, ...

In a recent legal development, Hindustan Unilever (NS: HLL) faced a setback regarding a tax dispute involving a significant ...

The application of IT for protecting and improving people’s health and the implementation of electronic medical records (EMR) ...

Global Sarcoma Therapeutics Market is valued at approximately USD 2.72 billion in 2023 and is anticipated to grow at a significant compound annual growth rate (CAGR) of 8.51% over the forecast period ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...

Sanofi has received two separate bids from private equity firms for its consumer health unit, which could be valued at 15 ...

A groundbreaking study will investigate Parkinson’s disease in unprecedented detail, with the aim of discovering a cure for the condition.

GSK PLC GSK shares inched up 0.20% to £15.31 Tuesday, on what proved to be an all-around favorable trading session for the ...

If approved, AZN's Fasenra will be the second biologic approved in the European Union to treat eosinophilic granulomatosis ...

UCB and Biogen revealed that their Phase 3 study testing dapirolizumab pegol in people with systemic lupus erythematosus met ...